Repaglinide 0.50 mg + Voglibose 0.30 mg + Metformin 500.00 mg

VOGLI RAPID 0.5mg | 0.3mg is a fixed-dose combination medication that contains Voglibose (0.30 mg/tablet), Repaglinide (0.50 mg/tablet), and Metformin (500.00 mg/tablet). Voglibose is an alpha-glucosidase inhibitor that helps control postprandial (after meal) blood glucose levels by delaying the absorption of carbohydrates in the intestine. Repaglinide is a fast-acting insulin secretagogue that stimulates insulin release from the pancreas and helps to lower blood glucose levels. Metformin is a biguanide that improves insulin sensitivity and reduces glucose production in the liver. This combination medication is prescribed to individuals with type 2 diabetes to help maintain glycemic control. It is usually taken in conjunction with diet and exercise.

Take VOGLI RAPID 0.5mg | 0.3mg orally with meals or as directed by your doctor. The dosage will depend on your medical condition and response to treatment. It is important to follow your doctor's instructions and monitor your blood sugar levels regularly.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.